BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fragoulis GE, Panayotidis I, Nikiphorou E. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment. Curr Vasc Pharmacol 2020;18:431-46. [PMID: 31258091 DOI: 10.2174/1570161117666190619143842] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Manolis AS, Tzioufas AG. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases. Curr Vasc Pharmacol 2020;18:533-7. [PMID: 32693768 DOI: 10.2174/1570161118666200721145718] [Reference Citation Analysis]
2 Nikiphorou E, Santos EJF, Marques A, Böhm P, Bijlsma JW, Daien CI, Esbensen BA, Ferreira RJO, Fragoulis GE, Holmes P, McBain H, Metsios GS, Moe RH, Stamm TA, de Thurah A, Zabalan C, Carmona L, Bosworth A. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann Rheum Dis 2021:annrheumdis-2021-220249. [PMID: 33962964 DOI: 10.1136/annrheumdis-2021-220249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Manolis AS, Tzioufas AG. Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target? Curr Vasc Pharmacol 2020;18:425-30. [PMID: 32410564 DOI: 10.2174/1570161118666200514222236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Fragoulis GE, Soulaidopoulos S, Sfikakis PP, Dimitroulas T, D Kitas G. Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction. J Inflamm Res 2021;14:1915-31. [PMID: 34017189 DOI: 10.2147/JIR.S282691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A. Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmun Rev 2021;20:102776. [PMID: 33609792 DOI: 10.1016/j.autrev.2021.102776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Czókolyová M, Pusztai A, Végh E, Horváth Á, Szentpéteri A, Hamar A, Szamosi S, Hodosi K, Domján A, Szántó S, Kerekes G, Seres I, Harangi M, Paragh G, Szekanecz É, Szekanecz Z, Szűcs G. Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology. Biomolecules 2021;11:1535. [PMID: 34680168 DOI: 10.3390/biom11101535] [Reference Citation Analysis]
7 Wang Q, Zhang M, Wang M, Tai Y, Tao J, Zhou W, Han Y, Wei Wei. Triggers of Cardiovascular Diseases in Rheumatoid Arthritis. Curr Probl Cardiol 2021;:100853. [PMID: 34016483 DOI: 10.1016/j.cpcardiol.2021.100853] [Reference Citation Analysis]
8 Hafström I, Ajeganova S, Andersson ML, Bala SV, Bergman S, Bremander A, Forslind K, Malm K, Svensson B. A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis - results of clinical relevance. Open Access Rheumatol 2019;11:207-17. [PMID: 31565006 DOI: 10.2147/OARRR.S218448] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Hsu CY, Su YJ, Chen JF, Sun CC, Cheng TT, Tsai TH, Lin SH, Chang CC, Chen TH. Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs at a Higher Risk of Acute Coronary Syndrome. J Am Heart Assoc 2021;10:e018290. [PMID: 33860677 DOI: 10.1161/JAHA.120.018290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]